by Annie De Groot | Oct 23, 2019 | Featured, News, Thinking Out Loud -Blog
Announced today, Chugai Pharmaceutical Co., Ltd. (“Chugai”), a member of the Roche Group, will extend the company’s licensed access to the Immunogenicity Screening and Protein Reengineering Interface (ISPRI) toolkit developed by EpiVax, Inc....
by Annie De Groot | Jul 14, 2019 | Events
11th Annual Protein & Antibody Engineering Summit (PEGS) Europe Monday, November 18th – Friday, November 22nd Lisbon Congress Center Lisbon, Portugal Our European Representative, Paul Von Hoegen, and Business Development Associate, Sarah Moniz, will be...
by Annie De Groot | Jun 29, 2019 | Events
Updated: Thank you to those that joined us for the seminar! It was a successful meeting with many wonderful talks. Please find photos from the event here as well as slide decks from some of our speakers. Welcome to Immunogenicity and Tolerance; Anne De Groot...
by Annie De Groot | Jun 28, 2019 | Events
TIDES Europe: Oligonucleotide and Peptide Therapeutics Tuesday, November 12th – Friday, November 15th RAI Amsterdam Convention Centre Amsterdam, Netherlands Right before our annual Immunogenicity and Tolerance seminar in Amsterdam, you will find us partnering at...
by Annie De Groot | Jun 28, 2019 | Events
UPDATE: Review Dr. Anne De Groots presentation here Therapeutic Peptides and Oligonucleotides: Regulations, Standards and Quality USP Workshop Monday, November 4th – Tuesday, November 5th The U.S. Pharmacopoeia (USP) Therapeutic Peptides and Oligonucleotides:...
